𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Current status of the taxanes as adjuvant therapy for breast cancer

✍ Scribed by Clifford Hudis; Heather McArthur; Chau Dang

Book ID
113506927
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
147 KB
Volume
16
Category
Article
ISSN
0960-9776

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Taxanes as adjuvant for breast cancer
Taxanes as adjuvant for breast cancer
✍ Aron Goldhirsch; Prudence Francis; Monica Castiglione-Gertsch; Richard D Gelber; πŸ“‚ Article πŸ“… 2000 πŸ› The Lancet 🌐 English βš– 96 KB
Current and future status of adjuvant th
Current and future status of adjuvant therapy for breast cancer
✍ Robert E. Coleman πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

Adjuvant systemic treatments have greatly improved the prognosis of women with early breast cancer. Combination chemotherapy and, for patients with oestrogen receptor-positive (ER+) tumours, endocrine treatment has been found to reduce the frequency of relapse and improve survival. New adjuvant stra

GRP78 as potential predictor for breast
GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy
✍ Eunjung Lee; Peter Nichols; Susan Groshen; Darcy Spicer; Amy S. Lee πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 241 KB

## Abstract Few predictive markers exist for response to adjuvant chemotherapy in breast cancer. The 78‐kDa glucose‐regulated protein (GRP78) is a potent antiapoptotic factor, conferring drug resistance. Recently, we reported that high GRP78 expression in breast cancer specimens predicts a shorter